Insights

Strategic Partnership Potential MedImmune has a history of successful partnerships with prominent pharmaceutical companies like Sanofi for the development of innovative biologic products, showcasing potential for strategic collaboration opportunities.

Cutting-Edge Vaccine Development With a focus on developing advanced vaccines, such as the monoclonal antibody MEDI8897 for respiratory syncytial virus (RSV), MedImmune presents sales opportunities within the field of preventative healthcare solutions.

Biotech Acquisition Prospects Following its acquisition by AstraZeneca for $15.6B, MedImmune's innovative biologics research arm positions it as an attractive target for biotech acquisitions, offering potential sales opportunities for investors or industry players.

Innovative R&D Capabilities Being part of a global R&D network and known for pioneering research across various therapeutic areas, MedImmune's innovative capabilities present opportunities for licensing agreements or technology partnerships to enhance product portfolios.

Market Expansion Possibilities As a subsidiary of AstraZeneca, MedImmune benefits from a strong market presence and financial backing, making it an appealing partner for expansion strategies into new geographic regions or markets.

Similar companies to MedImmune

MedImmune Tech Stack

MedImmune uses 8 technology products and services including PostgreSQL, GMX, Oracle, and more. Explore MedImmune's tech stack below.

PostgreSQL
Database
GMX
Email Hosting
Oracle
Enterprise
AngularJS
Javascript Frameworks
jQuery
Javascript Libraries
Node.js
Programming Languages
Java
Programming Languages
JavaScript
Programming Languages

Media & News

MedImmune's Email Address Formats

MedImmune uses at least 2 format(s):

MedImmune Email Formats	Example	Percentage
LastF@medimmune.com	DoeJ@medimmune.com	82%
First.Last@medimmune.com	John.Doe@medimmune.com	12%
LastFi@medimmune.com	DoeJo@medimmune.com	4%
FirstL@medimmune.com	JohnD@medimmune.com	2%
First.Last@aviron.com	John.Doe@aviron.com	50%
FLast@aviron.com	JDoe@aviron.com	50%

Frequently Asked Questions

Where is MedImmune's headquarters located?

MedImmune's main headquarters is located at 1 MedImmune Way Gaithersburg, Maryland 20878 US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is MedImmune's phone number?

You can contact MedImmune's main corporate office by phone at

+1-301-398-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MedImmune's stock symbol?

MedImmune is a publicly traded company; the company's stock symbol is MEDI1.

What is MedImmune's official website and social media links?

MedImmune's official website is medimmune.com and has social profiles on LinkedIn.

How much revenue does MedImmune generate?

As of November 2024, MedImmune's annual revenue reached $1.6B.

What is MedImmune's SIC code NAICS code?

MedImmune's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 325412 - Pharmaceutical Preparation Manufacturing.

How many employees does MedImmune have currently?

As of November 2024, MedImmune has approximately 1K employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: J. B.Chief Executive Officer: M. L.Chief Executive Officer: S. S. D.. Explore MedImmune's employee directory with LeadIQ.

What industry does MedImmune belong to?

MedImmune operates in the Biotechnology Research industry.

What technology does MedImmune use?

MedImmune's tech stack includes PostgreSQLGMXOracleAngularJSjQueryNode.jsJavaJavaScript.

What is MedImmune's email format?

MedImmune's email format typically follows the pattern of . Find more MedImmune email formats with LeadIQ.

When was MedImmune founded?

MedImmune was founded in 1987.

MedImmune

Biotechnology ResearchMaryland, United States1001-5000 Employees

MedImmune is the global biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines. MedImmune is pioneering innovative research and exploring novel pathways across Oncology, Respiratory, Cardiovascular, Renal and Metabolic Diseases, and Infection and Vaccines. The MedImmune headquarters is located in Gaithersburg, Md., one of AstraZeneca’s three global R&D centres, with additional sites in Cambridge, UK and South San Francisco, CA. 

For more information, please visit www.medimmune.com